Munafa Stock Market Course + Intraday & FNO calls 
Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)
Technical Analysis Report for USA stock NTLA Intellia Therapeutics. Dated: 03 Jun 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics
Intellia Therapeutics Opened at 13.14 and Closed at: 13.02, which is -0.92% of previous session's close. It moved within a range of 12.47 and 13.21
The session was a Bearish session with an average volume of 1954454, which is -48.12% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- Even though the stock has fallen, but its long term trend is positive and in an uptrend.
A Dead cross was found 9 days back on short term averages
Support for tomorrow is 12.38 and resistance for tomorrow is 13.12
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 12.59, 12.16 resistance for tomorrow's hourly charts is 13.33, 13.64
10 Day SMA for Intellia Therapeutics (NTLA) is 13.09 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Intellia Therapeutics (NTLA) is 13.33 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Intellia Therapeutics (NTLA) is 13.61 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 13.3 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Intellia Therapeutics is 13.31 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Intellia Therapeutics is at 13.33 and 200 DMA is at 13.31, while 50 DMA and 100 DMA are at 13.61 and 13.3 respectively
Intellia Therapeutics (NTLA) moving average of 20 SMA is at 13.33 and 20 EMA is at 13.34
| Date | Closing Price | 20 SMA | 20 EMA |
| 03 Wed Jun | 13.02 | 13.33 | 13.34 |
| 02 Tue Jun | 13.14 | 13.37 | 13.37 |
| 01 Mon Jun | 13.74 | 13.38 | 13.39 |
| 29 Fri May | 14.06 | 13.39 | 13.35 |
| 28 Thu May | 13.68 | 13.35 | 13.28 |
| 27 Wed May | 13.44 | 13.34 | 13.24 |
Intellia Therapeutics (NTLA) moving average of 50 SMA is at 13.61 and 50 EMA is at 13.39
| Date | Closing Price | 50 SMA | 50 EMA |
| 03 Wed Jun | 13.02 | 13.61 | 13.39 |
| 02 Tue Jun | 13.14 | 13.61 | 13.41 |
| 01 Mon Jun | 13.74 | 13.61 | 13.42 |
| 29 Fri May | 14.06 | 13.59 | 13.41 |
| 28 Thu May | 13.68 | 13.57 | 13.38 |
| 27 Wed May | 13.44 | 13.57 | 13.37 |
Intellia Therapeutics (NTLA) moving average of 100 SMA is at 13.3 and 100 EMA is at 13.19
| Date | Closing Price | 100 SMA | 100 EMA |
| 03 Wed Jun | 13.02 | 13.3 | 13.19 |
| 02 Tue Jun | 13.14 | 13.28 | 13.19 |
| 01 Mon Jun | 13.74 | 13.25 | 13.19 |
| 29 Fri May | 14.06 | 13.21 | 13.18 |
| 28 Thu May | 13.68 | 13.16 | 13.16 |
| 27 Wed May | 13.44 | 13.12 | 13.15 |
Intellia Therapeutics (NTLA) moving average of 200 SMA is at 13.31 and 200 EMA is at 12.85
| Date | Closing Price | 200 SMA | 200 EMA |
| 03 Wed Jun | 13.02 | 13.31 | 12.85 |
| 02 Tue Jun | 13.14 | 13.3 | 12.85 |
| 01 Mon Jun | 13.74 | 13.29 | 12.85 |
| 29 Fri May | 14.06 | 13.27 | 12.84 |
| 28 Thu May | 13.68 | 13.26 | 12.83 |
| 27 Wed May | 13.44 | 13.24 | 12.82 |
Smith Nephew has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Smith Nephew, about 4.9% more returns!
Intellia Therapeutics has performed better than Arcus Biosciences in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Novo Nordisk in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Brookdale Senior in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Xenon Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Scholar Rock has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Scholar Rock, about 0.75% more returns!
Sanofi has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Sanofi, about 2.79% more returns!
Intellia Therapeutics has performed better than Surgery Partners in short term. Holding Intellia Therapeutics could be a better choice for now!
Ptc Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Ptc Therapeutics, about 9.16% more returns!
Pacira Pharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Pacira Pharmaceuticals, about 0.21% more returns!
Intellia Therapeutics has performed better than Phibro Animal in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Kodiak Sciences in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Intuitive Surgical in short term. Holding Intellia Therapeutics could be a better choice for now!
Iradimed Corporation has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Iradimed Corporation, about 11.65% more returns!
Innoviva Inc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Innoviva Inc, about 2.35% more returns!
Cytokinetics Incorporated has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 0.47% more returns!
Intellia Therapeutics has performed better than Collegium Pharmaceutical in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Benitec Biopharma in short term. Holding Intellia Therapeutics could be a better choice for now!
Angiodynamics Inc has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Angiodynamics Inc, about 7.35% more returns!
Intellia Therapeutics Technical analysis of indicators
Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Intellia Therapeutics in short term but the buy signal is initial and weak.
Intellia Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Intellia Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Intellia Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 13.15 and Intellia Therapeutics NTLA stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.
Intellia Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NTLA Experts View which covers a lot of information including buying and selling signals
NTLA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
